ASCO has instituted a COVID-19 Clinical Questions Advisory Group to assist in the development of these resource pages. Its membership and declarations are available.

ASCO has developed the patient care guidance available on this page in the following fashion:

• ASCO determines the topics to be addressed based on questions that are received from ASCO members and others, as well as input from ASCO staff and the COVID-19 Clinical Questions Advisory Group.
• For each topic, ASCO staff work with the COVID-19 Clinical Questions Advisory Group to develop guidance in an iterative, collaborative fashion.  This guidance refers to and highlights, where possible, evidence published in the peer-reviewed literature as well as guidance issued by national and local health authorities and professional organizations (e.g. Centers for Disease Control and Prevention (CDC), American Heart Association (AHA) and American Society for Radiation Oncology (ASTRO), etc.).
• Once draft guidance is developed for the topic, it is reviewed by ASCO’s Chief Medical Officer and Executive Vice President, who approves all statements regarding patient care.
• Approved guidance is then posted on the page.

The guidance is updated as new information emerges and all content is reviewed periodically in its entirety by ASCO staff to ensure consistency with rapidly changing guidance from other organizations and government agencies. The date of the last review/update is at the top of each page.